Isomorphic Labs Raises $5 Billion for AI Drug Design

Article The Defiant 4 reads

Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials, with Alphabet investing again.

Read the full story at The Defiant ↗

This is the summary The Defiant publishes in its feed. The full article lives on their site.